The Use of "Smart" Body-Weight Scales for Weight and Nutritional Monitoring in Patients With Head and Neck Cancer Undergoing Radiation Therapy

PRIMARY OBJECTIVE: I. To determine the feasibility of "smart" body scales in patients undergoing radiation therapy for head and neck cancer. SECONDARY OBJECTIVE: I. MD Anderson Symptom Inventory for Head and Neck Cancer (MDASI-HN) questionnaire, overall pain scores, and weight loss percentage. OUTLINE: Patients are assigned to 1 of 2 cohorts. COHORT I: Patients weigh themselves daily using the "Smart" scale over 5-8 weeks during standard radiation therapy. COHORT II: Patients do not weigh themselves using the "Smart" scale during standard radiation therapy. After completion of study intervention, patients are followed up within 2 weeks and 3 months post-radiation therapy.